Stay updated with breaking news from Castle Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Rating) – Research analysts at SVB Leerink lowered their Q2 2022 earnings estimates for shares of Castle Biosciences in a report released on Monday, May 9th. SVB Leerink analyst P. Souda now anticipates that the company will post earnings of ($0.65) per share for the quarter, down from their […]
Brokerages forecast that Castle Biosciences, Inc. (NASDAQ:CSTL – Get Rating) will announce $25.13 million in sales for the current quarter, according to Zacks. Two analysts have issued estimates for Castle Biosciences’ earnings. The lowest sales estimate is $24.90 million and the highest is $25.35 million. Castle Biosciences posted sales of $22.81 million during the same […]
Houston-based company will pay $65 million in cash and stock for AltheaDx, which makes a pharmacogenomics tests to guide clinicians on drug therapies for depression and anxiety.
Wall Street brokerages expect that Castle Biosciences, Inc. (NASDAQ:CSTL – Get Rating) will report $25.13 million in sales for the current quarter, Zacks reports. Two analysts have issued estimates for Castle Biosciences’ earnings. The lowest sales estimate is $24.90 million and the highest is $25.35 million. Castle Biosciences reported sales of $22.81 million in the […]
A live audio webcast of the company’s presentation will be available by visiting Castle Biosciences’ website at https://ir.castlebiosciences.com/events-presentations/default.aspx . A replay of the webcast will be available for two weeks following the conclusion of the live broadcast.